KALA BIO, INC. Finance Lease, Liability, to be Paid, Year Three
KALA BIO, INC. (KALA) had Finance Lease, Liability, to be Paid, Year Three of $41.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree · last filed 2019-11-07
- 2019-09-30: Finance Lease, Liability, to be Paid, Year Three $41.00K.
- 2019-06-30: Finance Lease, Liability, to be Paid, Year Three $41.00K.
- 2019-03-31: Finance Lease, Liability, to be Paid, Year Three $41.00K.
| Period end | Finance Lease, Liability, to be Paid, Year Three |
|---|---|
| 2019-09-30 | $41.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $41.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $41.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |